메뉴 건너뛰기
The Lancet
Volumn 376, Issue 9743, 2010, Pages 769-770
The International study of insulin and cancer
Author keywords

[No Author keywords available]
Indexed keywords

HUMAN INSULIN; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; ORAL ANTIDIABETIC AGENT; ORAL CONTRACEPTIVE AGENT;
EID: 77956380296     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61374-8     Document Type: Letter
Times cited : (14)
References (5)
  • 1
    • 68449104156 scopus 로고    scopus 로고
    • Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: A cohort study
    • LG Hemkens, U Grouven, R Bender Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study Diabetologia 52 2009 1732 1744
    • (2009) Diabetologia , vol.52 , pp. 1732-1744
    • Hemkens, L.G.1    Grouven, U.2    Bender, R.3
  • 2
    • 68449104625 scopus 로고    scopus 로고
    • Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden
    • JM Jonasson, R Ljung, M Talback Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden Diabetologia 52 2009 1745 1754
    • (2009) Diabetologia , vol.52 , pp. 1745-1754
    • Jonasson, J.M.1    Ljung, R.2    Talback, M.3
  • 3
    • 68449094354 scopus 로고    scopus 로고
    • Use of insulin glargine and cancer incidence in Scotland: A study from the Scottish Diabetes Research Network Epidemiology Group
    • SDRN Epidemiology Group H.M.
    • HM Colhoun SDRN Epidemiology Group Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group Diabetologia 52 2009 1755 1765
    • (2009) Diabetologia , vol.52 , pp. 1755-1765
    • Colhoun, H.M.1
  • 4
    • 68449094325 scopus 로고    scopus 로고
    • The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
    • CJ Currie, CD Poole, EA Gale The influence of glucose-lowering therapies on cancer risk in type 2 diabetes Diabetologia 52 2009 1766 1777
    • (2009) Diabetologia , vol.52 , pp. 1766-1777
    • Currie, C.J.1    Poole, C.D.2    Gale, E.A.3
  • 5
    • 68349148204 scopus 로고    scopus 로고
    • Insulin glargine and malignancy: An unwarranted alarm
    • SJ Pocock, L Smeeth Insulin glargine and malignancy: an unwarranted alarm Lancet 374 2009 511 513
    • (2009) Lancet , vol.374 , pp. 511-513
    • Pocock, S.J.1    Smeeth, L.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.